Jiangsu Nanfang Medical Co (SHSE:603880) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603880 Jiangsu Nanfang Medical Co Ltd SHSE:603880
50 GF Score
Price ¥6.37
GF Value ¥4.71
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jiangsu Nanfang Medical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Jiangsu Nanfang Medical Co Valuation Rank Related Terms

SHSE:603880
50GF Score
Jiangsu Nanfang Medical Co Ltd SHSE:603880
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jiangsu Nanfang Medical Co (SHSE:603880) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co stock appears to be overvalued. The current stock price of ¥6.37 is trading 35.2% above its estimated GF Value™ of ¥4.71. GuruFocus considers Jiangsu Nanfang Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603880:

  • Valuation Rank:
  • GF Value™: ¥4.71 vs. price of ¥6.37 (35.2% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Nanfang Medical Co Business Description

Address Guo Xiang Road, Economic Development Zone, Jiangsu Province, Wujin, CHN, 213149
Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.
50GF Score

Get the complete analysis for SHSE:603880

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.37
Price
¥4.71
GF Value